| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |